Elaine H Morrato

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado at Denver, Aurora, CO 80045 0508, USA
    J Clin Psychiatry 69:316-22. 2008
  2. ncbi Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, Management and Policy Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Clin Psychopharmacol 29:26-32. 2009
  3. ncbi Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
  4. ncbi Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
  5. ncbi Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
  6. ncbi Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes
    Elaine H Morrato
    Departments of Pediatrics, Health Services Management and Policy, and Clinical Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:1037-42. 2009
  7. ncbi Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
  8. ncbi How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, School of Pharmacy, Denver, CO 80262, USA
    Curr Med Res Opin 23:2567-76. 2007
  9. ncbi Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Am J Psychiatry 164:1198-205. 2007
  10. ncbi Prevalence of multiple cardiac risk factors in US adults with diabetes
    Marianne McCollum
    School of Pharmacy, University of Colorado at Denver and Health Sciences, Denver, CO 80262, USA
    Curr Med Res Opin 22:1031-4. 2006

Detail Information

Publications13

  1. ncbi Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado at Denver, Aurora, CO 80045 0508, USA
    J Clin Psychiatry 69:316-22. 2008
    ..This study aimed to determine the prevalence of serum glucose and lipid monitoring in public mental health clients initiating second-generation antipsychotic (SGA) drugs...
  2. ncbi Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, Management and Policy Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045 0508, USA
    J Clin Psychopharmacol 29:26-32. 2009
    ..This study evaluated the association between abnormal blood glucose and lipid values and SGA prescribing patterns...
  3. ncbi Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs
    Elaine H Morrato
    Department of Pediatrics, School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA
    Arch Gen Psychiatry 67:17-24. 2010
    ..The American Diabetes Association (ADA) and American Psychiatric Association (APA) recommended glucose and lipid testing for all patients starting to receive SGA drugs...
  4. ncbi Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Colorado School of Public Health, University of Colorado Denver, Aurora, CO 80045, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  5. ncbi Metabolic screening in children receiving antipsychotic drug treatment
    Elaine H Morrato
    Department of Health Systems, Management, and Policy, Colorado School of Public Health, University of Colorado at Denver, Aurora, Colorado 80045, USA
    Arch Pediatr Adolesc Med 164:344-51. 2010
    ..To estimate metabolic screening rates, predictors of screening, and incidence of metabolic disturbances in children initiating second-generation antipsychotic (SGA) drug treatment...
  6. ncbi Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes
    Elaine H Morrato
    Departments of Pediatrics, Health Services Management and Policy, and Clinical Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Diabetes Care 32:1037-42. 2009
    ..We evaluated whether glucose and lipid testing increased after the American Diabetes Association (ADA) consensus statement recommending metabolic monitoring for SGA-treated patients...
  7. ncbi Small area variation and geographic and patient-specific determinants of metabolic testing in antipsychotic users
    Elaine H Morrato
    Department of Health Systems, Management and Policy, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, USA
    Pharmacoepidemiol Drug Saf 20:66-75. 2011
    ..We estimated glucose and lipid testing rates among SGA-users from three state Medicaid programs and investigated small area variation and patient and geographic determinants of testing...
  8. ncbi How expensive is antipsychotic polypharmacy? Experience from five US state Medicaid programs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, School of Pharmacy, Denver, CO 80262, USA
    Curr Med Res Opin 23:2567-76. 2007
    ..To characterize healthcare costs associated with antipsychotic polypharmacy and to investigate predictors of high-cost patients...
  9. ncbi Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs
    Robert J Valuck
    University of Colorado at Denver and Health Sciences Center, Denver, CO 80262, USA
    Am J Psychiatry 164:1198-205. 2007
    ..The authors examine the effects of this pediatric policy on treatment of adult depression in the community...
  10. ncbi Prevalence of multiple cardiac risk factors in US adults with diabetes
    Marianne McCollum
    School of Pharmacy, University of Colorado at Denver and Health Sciences, Denver, CO 80262, USA
    Curr Med Res Opin 22:1031-4. 2006
    ..This study estimates the national prevalence of additional CHD risk factors for US adults with and without DM and heart disease using Medical Expenditure Panel Survey (MEPS) data...
  11. ncbi Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002
    Patrick W Sullivan
    Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Care 28:1599-603. 2005
    ..The objective of this research is to determine the relative associations of physical activity and BMI with the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S...
  12. ncbi Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs
    Anne M Libby
    University of Colorado at Denver and Health Sciences Center, School of Medicine, Nighthorse Campbell Native Health Building, PO Box 6508, Campus Box F800, Aurora, CO 80045 0508, USA
    Am J Psychiatry 164:884-91. 2007
    ....
  13. ncbi Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
    Elaine H Morrato
    Department of Pediatrics, Preventive Medicine and Biometrics, and Clinical Pharmacy, University of Colorado at Denver and Health Sciences Center, Aurora, CO 80045, USA
    J Public Health (Oxf) 29:463-71. 2007
    ..The desire for evidence-based health policy and practice is well established. Routine population-based health information systems play a fundamental role to inform policy decisions and to evaluate their effectiveness...